1. Home
  2. MBBC vs HIND Comparison

MBBC vs HIND Comparison

Compare MBBC & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

HOLD

Current Price

$12.18

Market Cap

33.5M

Sector

Finance

ML Signal

HOLD

HIND

Vyome Holdings Inc.

N/A

Current Price

$3.29

Market Cap

28.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MBBC
HIND
Founded
1902
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
28.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
MBBC
HIND
Price
$12.18
$3.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2K
N/A
Earning Date
02-22-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.11
N/A
Revenue
$7,299,708.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$106.88
N/A
Revenue Growth
7.77
N/A
52 Week Low
$8.74
N/A
52 Week High
$12.89
N/A

Technical Indicators

Market Signals
Indicator
MBBC
HIND
Relative Strength Index (RSI) 59.69 34.02
Support Level $11.93 $3.11
Resistance Level $12.40 $3.69
Average True Range (ATR) 0.29 0.25
MACD -0.01 -0.02
Stochastic Oscillator 77.60 22.86

Price Performance

Historical Comparison
MBBC
HIND

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.

Share on Social Networks: